Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | R683S |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK2 R683S lies within the protein kinase domain 1 of the Jak2 protein (UniProt.org). R683S confers a gain of function to the Jak2 protein as demonstrated by constitutive Jak2 phosphorylation (PMID: 18805579), Stat5 activation (PMID: 23748007), and increased cytokine-independent growth and proliferation in culture (PMID: 18805579, PMID: 19638629). |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 act mut JAK2 R683S |
Transcript | NM_004972.4 |
gDNA | chr9:g.5078362A>C |
cDNA | c.2049A>C |
Protein | p.R683S |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322194.1 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5078362A>C | c.2049A>C | p.R683S | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK2 mutant | childhood B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in pediatric patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | myelofibrosis | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of primary myelofibrosis (NCCN.org). | detail... |
JAK2 mutant | B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | essential thrombocythemia | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of essential thrombocythemia (NCCN.org). | detail... |